Why the study?
Does clarithromycin induce long QT syndrome in patients with atypical pneumonia?
Does clarithromycin induce long QT syndrome in patients with atypical pneumonia?
Highlights the risk of clarithromycin-induced long QT syndrome in patients treated for atypical pneumonia.
Answers are grounded in this paper and cite their sources.
May indicate clarithromycin-associated QT risk; single case leaves causality and incidence open.
Long QT syndrome develops for a number of reasons. The number of non-antiarrhythmic drugs reported to induce QT interval prolongation with or without torsade de pointes continues to increase. Clarithromycin is a macrolide antibiotic being increasingly used for the treatment of atypical pneumonia. In this paper, we describe a patient who developed long QT prolongation syndrome after receiving clarithromycin for the treatment of atypical pneumonia.
No takes yet. Share an insight, caveat, or question.
Çetin et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: